Esophageal ulceration following high-dose-rate intraluminal brachytherapy for esophageal cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 8256004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prophylaxis of esophageal ulceration was studied in 78 esophageal carcinoma patients after high-dose-rate intraluminal brachytherapy. Before the standard treatment regimen of radiotherapy was established, 15/17 patients developed ulcers. This decreased to 19/38 with the standard treatment regimen, and to 9/23 when antiulcer therapy was added (p < 0.01).
Medical subject headings
- Brachytherapy
- Esophageal Diseases
- Esophageal Neoplasms